DGAP-News: Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintenance trial in ulcerative colitis
DGAP-News: ABIVAX / Key word(s): Study results Abivax reports excellent one-year efficacy and safety data of ABX464 phase 2b maintena...